Single-cell proteomics | Liquid biopsy

Novel Myeloma Biomarkers

Novel Myeloma Biomarkers

Published in Nature Precision Oncology

Multiple myeloma (MM) is accompanied by alterations to the normal plasma cell (PC) proteome, leading to changes to the tumor microenvironment and disease progression. There is a great need for understanding the consequences that lead to MM progression and for the discovery of new biomarkers that can aid clinical diagnostics and serve as targets for therapeutics. This study demonstrates the applicability of utilizing the single-cell high-definition liquid biopsy assay (HDSCA) and imaging mass cytometry to characterize the proteomic profile of myeloma. In our study, we analyzed ~87,000 cells from seven patient samples (bone marrow and peripheral blood) across the myeloma disease spectrum and utilized our multiplexed panel to characterize the expression of clinical markers for PC classification, additional potential therapeutic targets, and the tumor microenvironment cells. Our analysis showed BCMA, ICAM3 (CD50), CD221, and CS1 (SLAMF7) as the most abundantly expressed markers on PCs across all myeloma stages, with BCMA, ICAM3, and CD221 having significantly higher expression levels on disease versus precursor PCs. Additionally, we identify significantly elevated levels of expression for CD74, MUM1, CD229, CD44, IGLL5, Cyclin D1, UBA52, and CD317 on PCs from overt disease conditions compared to those from precursor states.

The Benefits of Custom Illustrations

Etiam ultrices. Suspendisse in justo eu magna luctus suscipit. Sed lectus. Integer euismod lacus luctus magna. Quisque cursus, metus vitae pharetra auctor, sem massa mattis sem, at interdum magna. Ut orci risus, accumsan porttitor, cursus quis.

Vestibulum tincidunt malesuada tellus. Ut ultrices ultrices enim. Curabitur sit amet mauris. Morbi in dui quis est pulvinar ullamcorper. Nulla facilisi. Integer lacinia sollicitudin massa. Cras metus. Aenean lectus elit, fermentum non, convallis sagit.

The longer I live, the more I realize that I am never wrong about anything, and that all the pains I have so humbly taken to verify my notions have only wasted my time!

– George Bernard Shaw

Nulla quam. Aenean laoreet. Vestibulum nisi lectus, … Praesent libero. Sed cursus ante dapibus diam. Sed nisi. Nulla quis sem at nibh elementum imperdiet.

  • Etiam ultrices. Suspendisse in justo massa fusce non tortor.
  • Quisque volutpat condimentum velit class aptent taciti sodales.
  • Aenean lectus elit fermentum non convallis id sagittis neque porttitor.
  • Morbi lectus risus iaculis vel suscipit luctus nostra non massa.


Setayesh, S.M., Ndacayisaba, L.J., Rappard, K.E. et al. Targeted single-cell proteomic analysis identifies new liquid biopsy biomarkers associated with multiple myeloma. npj Precis. Onc. 7, 95 (2023).